Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Synthesis, In Vitro Screening and Docking Studies of New Thiosemicarbazide Derivatives as Antitubercular Agents.

Pitucha M, Karczmarzyk Z, Swatko-Ossor M, Wysocki W, Wos M, Chudzik K, Ginalska G, Fruzinski A.

Molecules. 2019 Jan 11;24(2). pii: E251. doi: 10.3390/molecules24020251.

2.

Antimycobacterial Activity of Cinnamaldehyde in a Mycobacterium tuberculosis(H37Ra) Model.

Sawicki R, Golus J, Przekora A, Ludwiczuk A, Sieniawska E, Ginalska G.

Molecules. 2018 Sep 18;23(9). pii: E2381. doi: 10.3390/molecules23092381.

3.

Do new N-substituted 3-amino-4-phenyl-5-oxo-pyrazolinecarboxamide derivatives exhibit antitubercular potential?

Swatko-Ossor M, Klimek K, Belcarz A, Kaczor AA, Pitucha M, Ginalska G.

Eur J Pharm Sci. 2018 Aug 30;121:155-165. doi: 10.1016/j.ejps.2018.05.024. Epub 2018 May 24.

PMID:
29802898
4.

Metal TiO2 Nanotube Layers for the Treatment of Dental Implant Infections.

Roguska A, Belcarz A, Zalewska J, Hołdyński M, Andrzejczuk M, Pisarek M, Ginalska G.

ACS Appl Mater Interfaces. 2018 May 23;10(20):17089-17099. doi: 10.1021/acsami.8b04045. Epub 2018 May 10.

PMID:
29718650
5.

IN VITRO ACTIVITY OF PEPTIDE FRACTIONS FROM IMPATIENS GLAN- DULIFERA AGAINST CARIES CAUSING BACTERIA.

Miazga-Karska M, Szewczyk K, Klimek K, Ginalska G.

Acta Pol Pharm. 2017 Mar;74(2):710-714. No abstract available.

6.

Behavior of new hydroxyapatite/glucan composite in human serum.

Borkowski L, Lübek T, Jojczuk M, Nogalski A, Belcarz A, Palka K, Hajnos M, Ginalska G.

J Biomed Mater Res B Appl Biomater. 2018 Oct;106(7):2653-2664. doi: 10.1002/jbm.b.34082. Epub 2018 Feb 6.

PMID:
29406618
7.

Nigella damascena L. Essential Oil-A Valuable Source of β-Elemene for Antimicrobial Testing.

Sieniawska E, Sawicki R, Golus J, Swatko-Ossor M, Ginalska G, Skalicka-Wozniak K.

Molecules. 2018 Jan 28;23(2). pii: E256. doi: 10.3390/molecules23020256.

8.

The Effect of Combining Natural Terpenes and Antituberculous Agents against Reference and Clinical Mycobacterium tuberculosis Strains.

Sieniawska E, Sawicki R, Swatko-Ossor M, Napiorkowska A, Przekora A, Ginalska G, Augustynowicz-Kopec E.

Molecules. 2018 Jan 15;23(1). pii: E176. doi: 10.3390/molecules23010176.

9.

The frequently occurring components of essential oils beta elemene and R-limonene alter expression of dprE1 and clgR genes of Mycobacterium tuberculosis H37Ra.

Sawicki R, Sieniawska E, Swatko-Ossor M, Golus J, Ginalska G.

Food Chem Toxicol. 2018 Feb;112:145-149. doi: 10.1016/j.fct.2017.12.052. Epub 2017 Dec 27.

PMID:
29288759
10.

Synthesis and in vitro antiproliferative and antibacterial activity of new thiazolidine-2,4-dione derivatives.

Trotsko N, Przekora A, Zalewska J, Ginalska G, Paneth A, Wujec M.

J Enzyme Inhib Med Chem. 2018 Dec;33(1):17-24. doi: 10.1080/14756366.2017.1387543.

11.

Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors.

Kolmas J, Pajor K, Pajchel L, Przekora A, Ginalska G, Oledzka E, Sobczak M.

Int J Nanomedicine. 2017 Aug 7;12:5633-5642. doi: 10.2147/IJN.S140935. eCollection 2017.

12.

New approach in evaluation of ceramic-polymer composite bioactivity and biocompatibility.

Borkowski L, Sroka-Bartnicka A, Polkowska I, Pawlowska M, Palka K, Zieba E, Slosarczyk A, Jozwiak K, Ginalska G.

Anal Bioanal Chem. 2017 Sep;409(24):5747-5755. doi: 10.1007/s00216-017-0518-0. Epub 2017 Jul 26.

13.

Novel thiosemicarbazide derivatives with 4-nitrophenyl group as multi-target drugs: α-glucosidase inhibitors with antibacterial and antiproliferative activity.

Wos M, Miazga-Karska M, Kaczor AA, Klimek K, Karczmarzyk Z, Kowalczuk D, Wysocki W, Ginalska G, Urbanczyk-Lipkowska Z, Morawiak M, Pitucha M.

Biomed Pharmacother. 2017 Sep;93:1269-1276. doi: 10.1016/j.biopha.2017.07.049.

PMID:
28747001
14.

LC-QTOF-MS Analysis and Activity Profiles of Popular Antioxidant Dietary Supplements in Terms of Quality Control.

Sieniawska E, Baj T, Sawicki R, Wanat A, Wojtanowski KK, Ginalska G, Zgorka G, Szymanska J.

Oxid Med Cell Longev. 2017;2017:8692516. doi: 10.1155/2017/8692516. Epub 2017 May 31.

15.
16.

The use of calcium ions instead of heat treatment for β-1,3-glucan gelation improves biocompatibility of the β-1,3-glucan/HA bone scaffold.

Klimek K, Przekora A, Benko A, Niemiec W, Blazewicz M, Ginalska G.

Carbohydr Polym. 2017 May 15;164:170-178. doi: 10.1016/j.carbpol.2017.02.015. Epub 2017 Feb 4.

PMID:
28325314
17.

Chitosan/β-1,3-glucan/hydroxyapatite bone scaffold enhances osteogenic differentiation through TNF-α-mediated mechanism.

Przekora A, Ginalska G.

Mater Sci Eng C Mater Biol Appl. 2017 Apr 1;73:225-233. doi: 10.1016/j.msec.2016.12.081. Epub 2016 Dec 18.

PMID:
28183603
18.

Evaluation of the potential of chitosan/β-1,3-glucan/hydroxyapatite material as a scaffold for living bone graft production in vitro by comparison of ADSC and BMDSC behaviour on its surface.

Przekora A, Vandrovcova M, Travnickova M, Pajorova J, Molitor M, Ginalska G, Bacakova L.

Biomed Mater. 2017 Feb 24;12(1):015030. doi: 10.1088/1748-605X/aa56f9.

PMID:
28054934
19.

Natural Terpenes Influence the Activity of Antibiotics against Isolated Mycobacterium tuberculosis.

Sieniawska E, Swatko-Ossor M, Sawicki R, Skalicka-Woźniak K, Ginalska G.

Med Princ Pract. 2017;26(2):108-112. doi: 10.1159/000454680. Epub 2016 Nov 23.

20.

Structural transformation of synthetic hydroxyapatite under simulated in vivo conditions studied with ATR-FTIR spectroscopic imaging.

Sroka-Bartnicka A, Borkowski L, Ginalska G, Ślósarczyk A, Kazarian SG.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 Jan 15;171:155-161. doi: 10.1016/j.saa.2016.07.051. Epub 2016 Aug 2.

PMID:
27513683

Supplemental Content

Loading ...
Support Center